Antibody deficiency in adults with 22q11.2 deletion syndrome

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 8, 2012, Pages 1934-1940

  Björk, Aron H ^a   Óskarsdóttir, Sólveig ^a   Andersson, Bengt A ^a   Friman, Vanda ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

22q11.2 deletion syndrome; Autoimmunity; Common variable immunodeficiency; DiGeorge syndrome; Immunodeficiency; Infections; Velocardiofacial syndrome

Indexed keywords

CONCANAVALIN A; FUNGUS ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; PHYTOHEMAGGLUTININ;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; CANDIDA ALBICANS; CD19+ LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHROMOSOME DELETION 22Q11; CHROMOSOME DELETION 22Q11.2; CHRONIC OTITIS MEDIA; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE SEVERITY; ENDOCARDITIS; FEMALE; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; INFECTION; JUVENILE RHEUMATOID ARTHRITIS; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; T LYMPHOCYTE; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; HUMANS; LYMPHOCYTE SUBSETS; MALE; YOUNG ADULT;

EID: 84864117699     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35484     Document Type: Article

References (29)

1. Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD, Gatzoulis MA. 2005. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet Part A 138A: 307-313.
2. Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, Hooijkaas H, van Dongen JJ. 1997. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 130: 388-393.
3. Conley ME, Notarangelo LD, Etzioni A. 1999. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93: 190-197.
4. Cunningham-Rundles C. 2008. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol 28: S42-S45.
5. Cunningham-Rundles C, Bodian C. 1999. Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 92: 34-48.
6. Finocchi A, Di Cesare S, Romiti ML, Capponi C, Rossi P, Carsetti R, Cancrini C. 2006. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatr Allergy Immunol 17: 382-388.
7. Gennery AR, Barge D, O'Sullivan JJ, Flood TJ, Abinun M, Cant AJ. 2002. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86: 422-425.
8. Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE. 2001. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr 139: 715-723.
9. Knight AK, Cunningham-Rundles C. 2006. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 5: 156-159.
10. Lima K, Abrahamsen TG, Wolff AB, Husebye E, Alimohammadi M, Kampe O, Folling I. 2011. Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. Eur J Endocrinol 165: 345-352.
11. Lima K, Folling I, Eiklid KL, Natvig S, Abrahamsen TG. 2010. Age-dependent clinical problems in a Norwegian national survey of patients with the 22q11.2 deletion syndrome. Eur J Pediatr 169: 983-989.
12. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ, Bradley A, Baldini A. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410: 97-101.
13. McLean-Tooke A, Barge D, Spickett GP, Gennery AR. 2008. Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol 122: 362-367, 367.e1-4.
14. McLean-Tooke A, Spickett GP, Gennery AR. 2007. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol 66: 1-7.
15. Oskarsdottir S, Holmberg E, Fasth A, Stromland K. 2008. Facial features in children with the 22q11 deletion syndrome. Acta Paediatr 97: 1113-1117.
16. Oskarsdottir S, Persson C, Eriksson BO, Fasth A. 2005. Presenting phenotype in 100 children with the 22q11 deletion syndrome. Eur J Pediatr 164: 146-153.
17. Oskarsdottir S, Vujic M, Fasth A. 2004. Incidence and prevalence of the 22q11 deletion syndrome: A population-based study in Western Sweden. Arch Dis Child 89: 148-151.
18. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. 2008. Common variable immunodeficiency: A new look at an old disease. Lancet 372: 489-502.
19. Perez E, Sullivan KE. 2002. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr 14: 678-683.
20. Pierdominici M, Marziali M, Giovannetti A, Oliva A, Rosso R, Marino B, Digilio MC, Giannotti A, Novelli G, Dallapiccola B, Aiuti F, Pandolfi F. 2000. T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome. Clin Exp Immunol 121: 127-132.
21. Pierdominici M, Mazzetta F, Caprini E, Marziali M, Digilio MC, Marino B, Aiuti A, Amati F, Russo G, Novelli G, Pandolfi F, Luzi G, Giovannetti A. 2003. Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Exp Immunol 132: 323-331.
22. Piliero LM, Sanford AN, McDonald-McGinn DM, Zackai EH, Sullivan KE. 2004. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 103: 1020-1025.
23. Rezaei N, Wing JB, Aghamohammadi A, Carlring J, Lees A, Asgarian-Omran H, Pourpak Z, Sarrafnejad A, Kardar GA, Shahrestani T, Masoumi F, Zare A, Saghafi S, Sarrafzadeh S, Foster RA, Heath AW, Read RC. 2010. B-cell-T-cell activation and interaction in common variable immunodeficiency. Hum Immunol 71: 355-362.
24. Scambler PJ, Kelly D, Lindsay E, Williamson R, Goldberg R, Shprintzen R, Wilson DI, Goodship JA, Cross IE, Burn J. 1992. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 339: 1138-1139.
25. Smith CA, Driscoll DA, Emanuel BS, McDonald-McGinn DM, Zackai EH, Sullivan KE. 1998. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 5: 415-417.
26. Stagg A, Knight SC, Webster AD, Farrant J. 1993. Failure of primary and secondary T cell responses in common variable immunodeficiency. Immunodeficiency 4: 13-14.
27. Sullivan KE. 2004. The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol 4: 505-512.
28. Sullivan KE, McDonald-McGinn DM, Driscoll DA, Zmijewski CM, Ellabban AS, Reed L, Emanuel BS, Zackai EH, Athreya BH, Keenan G. 1997. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum 40: 430-436.
29. Zemble R, Luning Prak E, McDonald K, McDonald-McGinn D, Zackai E, Sullivan K. 2010. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol 136: 409-418.